Cargando…
Hyperinflammation with COVID-19: The key to patient deterioration?()()
BACKGROUND: The potential risk of cytokine storm in patients with coronavirus disease 2019 (COVID-19) has been described [1]; we write to share our experience treating a 17-year-old male with haemophagocytic lymphohistiocytosis (HLH) secondary to COVID-19 infection. CASE REPORT: This patient present...
Autores principales: | Haigh, Kathryn, Syrimi, Zoe Joanna, Irvine, Sharon, Blanchard, Tom J., Pervaiz, Muhammad Sajid, Toth, Arpad G., Ratcliffe, Libuse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245680/ https://www.ncbi.nlm.nih.gov/pubmed/32838293 http://dx.doi.org/10.1016/j.clinpr.2020.100033 |
Ejemplares similares
-
Hereditary haemochromatosis, haemophagocytic lymphohistiocytosis and COVID-19
por: Riley, Matthew J., et al.
Publicado: (2020) -
Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021) -
Ferritin H deficiency deteriorates cellular iron handling and worsens Salmonella typhimurium infection by triggering hyperinflammation
por: Haschka, David, et al.
Publicado: (2021) -
Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022) -
Hyperinflammation, T cells, and endotoxemia
por: Inoue, Makoto, et al.
Publicado: (2015)